Debilitating diarrhoea and weight loss due to colitis in two RA patients treated with leflunomide

Clinical Rheumatology

Volumn 24, Issue 1, 2005, Pages 87-90

  Verschueren, Patrick ^a   Vandooren, A K ^a   Westhovens, R ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Colitis; Diarrhoea; Leflunomide; Rheumatoidarthritis (RA); Weightloss

Indexed keywords

ADALIMUMAB; BUDESONIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE SULFATE; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ABDOMINAL CRAMP; ADULT; ANOREXIA; ARTICLE; BODY WEIGHT DISORDER; CASE REPORT; CLINICAL EXAMINATION; COLON BIOPSY; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HEMORRHAGIC COLITIS; HISTOPATHOLOGY; HUMAN; NAUSEA; PATHOGENESIS; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGMOIDOSCOPY; TREATMENT OUTCOME; ULCERATIVE COLITIS; WEIGHT REDUCTION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; BIOPSY; COLITIS; COLON; COLONOSCOPY; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOXAZOLES; MIDDLE AGED; WEIGHT LOSS;

EID: 13444258034     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-1033-1     Document Type: Article

References (14)

1. Strand V, Cohen S, Schiff M et al., Leflunomide Rheumatoid Arthritis Investigators Group (1999) Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 159:2542-2550
2. Smolen JS, Kalden JR, Scott DL et al. (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multi-centre trial. Lancet 353:259-266 10.1016/S0140-6736(98)09403-3
3. Emery P, Breedveld FC, Lemmel EM et al., Multinational Leflunomide Study Group (2000) A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology 39:655-665
4. Kremer JM, Genovese MC, Cannon GW, Caldwell RJ, Cush JJ, Furst DE et al. (2002) Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. Ann Intern Med 137:716-733
5. Larsen A, Kvien TK, Schattenkirchner, Rau R, Scott DL et al., European Leflunomide Study Group (2001) Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine. Scand J Rheumatol 30:135-142 10.1080/030097401300162897
6. Mladenovic V, Domljan Z, Rozman B et al. (1995) Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomised, placebo-controlled, phase II study. Arthritis Rheum 38:1595-1603 1:CAS:528:DyaK28XjvFOhsw%3D%3D
7. Coblyn JS, Shadick N, Helfgott S (2001) Leflunomide-associated weight loss in rheumatoid arthritis. Arthritis Rheum 44:1048-1051 1:CAS:528:DC%2BD38Xpt10%3D
8. Kalden JR, Schattenkirchner M, Sörensen H et al. (2003) The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five-year follow-up study. Arthritis Rheum 48:1513-1520
9. Maes B, Dalle I, Geboes K et al. (2003) Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation 75:665-672 10.1097/01.TP.0000053753.43268.F0
10. Hammer B (1994) Current developments in the diagnosis and therapy of Crohn disease and ulcerative colitis. Schweiz Med Wochenschr 124:452-460 1:STN:280:ByuC1MnjtlY%3D
11. Davies NM, Can PD (1995) Toxicity of NSAIDs in the large intestine. Dis Colon Rectum 38:1311-1321
12. Wilcox GM, Mattia A (2002) Collagenous colitis associated with lansoprazole. J Clin Gastroenterol 34:164-166 10.1097/00004836-200202000-00013
13. Fernandez-Banares F, Salas A, Esteve M et al. (2003) Collagenous and lymphocytic colitis. Evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 98:340-347 10.1111/j.1572-0241.2003.07225.x
14. Püspök A, Kiener HP et al. (2000) Clinical, endoscopic and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum 43:685-691 10826432